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Abstract: Bacterial cellulose (BC) is a natural polymer that has fascinating attributes, such as biocom-
patibility, low cost, and ease of processing, being considered a very interesting biomaterial due to its
options for moldability and combination. Thus, BC-based compounds (for example, BC/collagen,
BC/gelatin, BC/fibroin, BC/chitosan, etc.) have improved properties and/or functionality, allowing
for various biomedical applications, such as artificial blood vessels and microvessels, artificial skin,
and wounds dressing among others. Despite the wide applicability in biomedicine and tissue engi-
neering, there is a lack of updated scientific reports on applications related to dentistry, since BC has
great potential for this. It has been used mainly in the regeneration of periodontal tissue, surgical
dressings, intraoral wounds, and also in the regeneration of pulp tissue. This review describes the
properties and advantages of some BC studies focused on dental and oral applications, including the
design of implants, scaffolds, and wound-dressing materials, as well as carriers for drug delivery in
dentistry. Aligned to the current trends and biotechnology evolutions, BC-based nanocomposites
offer a great field to be explored and other novel features can be expected in relation to oral and bone
tissue repair in the near future.
Keywords: bacterial cellulose; biomaterials; nanocomposites; tissue engineering; guided tissue re-
generation
1. Introduction
Biocompatible materials and devices have attracted a great deal of interest over the
past years in the medical field. Ongoing efforts from many researchers are providing novel
systems that mimic the main peculiar details of native tissues. Particularly, biocompatible
materials engineered with improved functionalities and complex design have been proved
to offer better cell adhesion, proliferation, and differentiation [1–4].
Generally, biomaterials are in direct contact with biological tissues and they can be
defined as part of a system that deals with improving or replacing any tissue, organ, or
body function [5]. Therefore, it is fundamental to carefully consider some requirements to
appoint a material as a biomaterial, such as excellent biocompatibility and biodegradability
and lack of toxicity.
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According to its chemical nature, biomaterials can be broadly classified into two
main categories: (I) Natural biomaterials, for example, collagen, silk, keratin, elastin, most
polysaccharides, and tissues, such as bovine pericardium; and (II) synthetic biomaterials,
which include ceramics, synthetic polymers, metals and alloys, and composites. Although
their obtention is simple with a relatively low cost, they can cause some collateral effects.
Noteworthy, natural biomaterials directly help in regulation of the cellular pheno-
type [1,6,7] in addition to enhancement of tissue biocompatibility. As an example, collagen,
a natural polymer, is the main organic compound of bone tissue, being widely explored in
manufacturing biomaterials. However, its high cost, handicap in quality control related
to contaminations, and standard commercial sources are challenging issues that hinder
its use [8].
Naturally occurring biopolymers, viz. collagen, hyaluronan, gelatin, chitosan, and
cellulose, are being explored in dentistry because their properties are like those of the native
tissue. Several strategies were carried out to produce BC micro and nanocomposites for
different biological and technological applications [9]. In particular, there is an emerging
and appealing interest in bacterial cellulose towards its use as dental material [10,11]. In
the pursuit to outline the known applicability and explore the ongoing efforts of BC in
odontology, this review highlights in detail several up-do-date reports covering biomedical
applications of BC in implants and scaffolds for tissue engineering, carriers for drug
delivery, wound dressing, and applications related to dental materials as graphically
summarized in Figure 1.
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2. Bacterial Cellulose
Plant cellulose is the most abundant natural biopolymer on Earth, being harvested
mainly from trees and cotton. Additionally, cellulose can also be produced by a wide
variety of living species, such as microorganisms. Specifically, the production of cellulose
from bacteria sources was first reported by Brown in 1886 [12]. Brown observed that the
Gram-negative bacteria Komagataeibacter xylinus (previously named as Gluconacetobacter
xylinus) was the only known species capable of producing cellulose on an industrial scale.
Today, there are several Gram(-) bacteria able to produce BC, such as Agrobacterium,
Pseudomonas, Rhizobium, and Escherichia spp. In an appropriate medium, these bacteria
secrete an abundant 3-D network of cellulose fibrils under aerobic conditions, using glucose
and other saccharides as a carbon source. The BC fibrils are condensed in a network located
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in the interphase of the culture media-air. The macroscopic aspect of the BC membrane
is similar to a gel (Figure 2a), whose form and thickness depend on the recipient and
cultivation time, respectively.
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igure 2b), which in turn are assembled by bundles of thinner cellulosic fibers with diameter
sizes down to the micro- and nanoscale. Compared to plant cellulose, BC fibers are free
of lignin a d hemic llulose, contain small fibrils (100 times lower than pl t cellulose),
and have a ighly crystalline structure [13–16]. Additionally, BC can be sterilized through
many treatments, such as heat, steam, ethylene oxide gas, and radiation, without losing its
intrinsic physicochemical properties and structural integrity.
BC fibrils are biosynthesized by polymerization of UDP-glucose into α-1,4-glucan
chains by multienzymatic complex in several steps. BC fibers possess a strong tendency for
self-assembly and form an extended network via both intramolecular and intermolecular
hydrogen bonds due to their strong surface-interacting hydroxyl groups [17,18], enabling
the production of sheets with a high surface area and porosity. Because of its uniform struc-
ture and morphology, the BC is endowed with peculiar characteristics, such as a high water
retention capacity, high purity and crystallinity, good chemical stability, and remarkable
mechanical properties [16]. Notwithstanding, BC unveils an exciting class of nanomaterial
and an ideal starting point for useful biomaterials to be applied in therapeutics.
BC can be obtained from bacterial cultures in many formats and for different purposes,
such as membranes under static culture conditions, and as micro- or nano-structures in
shaken cultures. Alternatively, BC membranes can be processed to obtain microcrystals
by physical (i.e., sonication) and/or chemical (i.e., sulfuric and nitric acids, periodate, etc.)
treatment [19,20], or by enzymatic modification to produce nanofibrils [21].
With regards to physical, mechanical, and biological properties Czaja et al. [22] re-
ported that BC could act as a physical barrier against microbial infections. Besides its low
cost, BC is a biomaterial of feasible sterilization and manipulation, and is a non-allergenic
and non-toxic material. In addition, the same authors reported that BC may significantly
decrease pain when applied as a dressing material during certain topical treatments.
The literature describes several in vivo studies in which BC was applied, from the
replacement of abdominal skin [23], dorsal implants [24], and brain and breast cancer
treatments in rats [25,26], to vascular stents [15,27,28]. Other studies revealing the use of
BC as artificial skin, artificial blood vessels and microvessels, wound dressing of second-
or third-degree burn ulcers, and dental implants [23] were also reported.
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Natural polymers and hydrogels (such as BC) possess many properties that make them
attractive for challenging reconstruction problems, such as neural tissue applications for
example [29]. Benefiting from high biocompatibility and bioadhesivity on living tissues BC
has been widely used as a scaffold for cellular growth and tissue engineering [16,24,30,31].
The refined natural 3-D nanofibers of BC networks are distinct from the usual scaffolding
due to the similarity of its shape to the collagen nanofibrils in natural tissue, such as
the umbilical cord [30] and basement membrane in the cornea [32]. In addition, some
researchers observed that endothelial, smooth muscle cells, and chondrocytes show good
adhesion to BC [13,33].
To emphasize the relevance of the subject, over the past decade, several BC-based
materials have been designed for a variety of biomedical applications, which has a marked
notable increase in the number of scientific reports since 2000. The reader is advised
to consult the cited review articles that highlight the potential applications of BC as a
biomaterial [10,34–41] and recently in dentistry [42].
3. A Brief Overview of BC Uses in Biomedicine Applications
One of the first designed and main direct applications of BC membranes in the biomed-
ical area is as a wound dressing in the replacement of burned skin [43]. Since then, the
literature has shown an increasing number of papers related to wound dressing. In terms
of a temporary covering, BC dressings are mightily recommended by manufacturers for the
treatment of different types of wounds, including skin tears, pressure sores, venous stasis,
second-degree burns, ischemic and diabetic wounds, traumatic abrasions and lacerations,
and skin graft and biopsy sites [44].
Currently, it is possible to identify the following BC-based wound dressings avail-
able on the market: Gengiflex® (for periodontal reconstruction), XCell®, Bioprocess®, and
BioFill® [45,46]. Within the mentioned brands, BioFill® represents one of the first commer-
cial products that fulfills the main requirements of an ideal wound dressing, including:
water vapor permeability, good adherence to the wound, transparency, elasticity, durability,
a physical barrier for bacteria, hemostatic, easy handling, and low cost with minimum
exchanges. In addition, BioFill®’s efficiency in accelerating the healing and pain relief
process has been successfully proven in more than 300 clinical trials in humans [22,45,46].
Additionally, it has been reported that the BC wound dressing clearly shortened wound
closure and/or the healing time over standard care when applied to non-healing lower
extremity ulcers in humans [22,47,48].
Likewise, Portal and co-workers [47] also observed the healing process by using BC
dressing (DermafillTM, AMD/Ritmed, Tonawanda, NY, USA) for chronic wounds. They
found a considerable reduction in wound closure time from 315 days to 81 days using a BC
membrane, with 75% of epithelialization of the affected areas.
Despite the fact that the analgesic mechanism of action and the sensation of pain
relief of these wound dressings is not yet fully understood, some authors suggested that
the healing could be related to the high number of hydroxylic groups. These hydroxylic
groups are able to retain a huge amount of water concomitantly with the capture of ions by
means of cellulose hydrogen bonds or by the nano BC 3-D network, which mimics the skin
surface, resulting in optimal conditions for healing and regeneration [22,46].
A variety of surface functionalization’s through biosynthetic or chemical modification
was also investigated by incorporating different substrates, including polymers, inorganic
nanoparticles or nanowires, and small molecules, on the surface of BC that can be easily
maneuvered, forming nanocomposites with fine-tuned properties. Therefore, several BC-
based nanocomposites have been developed with improved mechanical and mucoadhesive
properties, such as BC/collagen [49–52] and BC/gelatin [53,54].
Kim et al. [55] prepared wet BC-gelatin nanocomposites, and NIH3T3 fibroblast cells
were further seeded and compared with pure BC. After 48 h of incubation, they found
that the cells spread well, presenting good adhesion in both platforms, although the
biocompatibility was more superior in BC-gelatin composites than that of pure BC.
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Besides collagen and gelatin protein, nanocomposites of BC modified with naturally
occurring biopolymers, such as aloe vera, have been tailored as biomaterials for therapeutic
applications [56,57].
Lin et al. [58] reported the skin wound healing efficacy of BC membranes modified
with chitosan in experiments assessed with rat models. They found that the resulting
nanocomposite reduced the time for wound healing and did not produce any toxic effect
on animal cells.
BC/silk fibroin (SF) sponge-like scaffolds were obtained by Oliveira Barud et al. [40]
by means of the freeze-drying technique. These nanocomposites presented a non-cytotoxic
or genotoxic character as is possible to observe in SEM images, which showed a greater
number of L929 cells attached to the BC/SF: 50% scaffold surface when compared with
pure BC. The huge difference in terms of cell attachment may suggest that the presence
of fibroin improved and created optimal conditions. So, the SF amino acid sequence
may act as cell receptors guiding and allowing easy cell adhesion and growth (Figure 3),
pointing that BC/SF: 50% scaffolds represent an excellent option in bioengineering and
tissue regeneration in the cultivation of cells on nanobiocomposites.
Figure 3. SEM images of L-929 cells attached to BC (a) and BC/SF (b) scaffolds surface at 48 h; 10 
cross-section SEM images of BC (c) and BC/SF (d) evidenced that the cells did not migrate into 11 









Figure 3. SEM images of L-929 cells attached to BC (a) and BC/SF (b) scaffolds surface at 48 h; cross-section SEM images of
BC (c) and BC/SF (d) evidenced that the cells did not migrate into the scaffolds. Reprinted with permission from [40].
Other composites, such as BC-chitosan, BC-poly(ethylene glycol), and BC-collagen,
revealed improved NIH3T3 cell activity as compared to native BC [50,59]. On the other
hand, human adipose-derived stem cells proliferated on the BC-poly(2-hydroxyethyl
methacrylate) scaffold to a lower extent in comparison to pure BC membranes [60]. This
fact could be attributed to the presence of monomer residues present in the hybrid scaffold
structure as well as the partial biocompatibility of this compound since it is considered an
allergen [9].
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Nanocomposites with antimicrobial activity have been prepared by incorporating
silver nanoparticles [14,61,62]. Furthermore, BC nanocomposites modified with propolis, a
naturally occurring substance, have garnered a great deal of attention as biomaterials due
to its remarkable antifungal, antiviral, antioxidant, anti-inflammatory, and antibacterial
properties [63].
In recent years, several controlled release systems based on nanocellulose have been
conceived. Noteworthy, BC fibrils were used to deliver a myriad of drugs: Tetracycline [64],
benzalkonium chloride [65], topical release of lidocaine and ibuprofen [66,67], doxoru-
bicin [9], and release of proteins with serum albumin [68].
Focusing on vascular applications, a German group created BASYC® (Bacterial Cel-
lulose Synthetized), a tubular biomaterial to be used in microsurgery of arteries and
veins [27,28]. Similarly, Bodin et al. [69] modified the fermentation process of Komagataeibac-
ter xylinus using silicone guides to mold and obtain BC tubes.
Nimeskern et al. [70] designed the biofabrication of a patient-specific ear-shaped BC
implant as a prototype device by applying a 3-D bioprinter technique, which consists of a
high-precision motion and a microdispensing system to construct the device layer by layer.
The application of this modern and innovative technique confirms BC’s great potential in
bioengineering and as an ear cartilage replacement material with appropriate mechanical
properties.
Bent BC films have been fashioned by using a special machine in order to shape the
biocompatible wound dressing contact lens, seeking their use in the regeneration of cornea
tissue or as drug delivery systems [71].
Recently, an implant for a cell trap made of BC after glioblastoma brain surgery was
reported [25]. The work suggested that BC could concentrate and trap cancer cells without
impact on brain parenchyma and the visibility of BC scaffolds by magnetic resonance
imaging allowed increased precision of the stereotactic radiosurgery.
A plentiful number of works also unveil other interesting BC applications in tis-
sue engineering related to neural implants/dura máter [72–74], urinary conduits [75,76],
tympanic membrane [77,78], and vocal folds [79].
4. BC in Dentistry
Despite the great applicability in biomedicine and tissue engineering, BC-based mate-
rials are still poorly explored in dentistry.
There are few studies that evidence the applicability of BC in dental or oral fields.
Some of the first applications in the dental area were related to the guided tissue regen-
eration technique (GTR), aiming at periodontal disease treatment. The biologic basis of
GTR to promote periodontal regeneration is related to the placement of physical barriers
into specific sites, which will prevent apical migration of the epithelium and gingival
connective tissue cells and will allow an isolated area for the migration of mesenchymal
and periodontal ligament cells (PDL) over the exposed root surface. The role of physical
barriers goes far beyond aesthetic appeal: besides further selective repopulation of the
affected area by the maintenance for ingrowth of a new periodontal tissue, they provide
protection of the blood clot during early cicatrization stages. However, GTR membranes
have limited clinical efficacy on biologic effects related to not providing differentiation and
the proliferation of mesenchymal and PDL cells [80,81].
Among the lesions treated by GTR are class II furcation lesions, two-to-three wall in-
frabone defects, extensive defects combined or not with other techniques, bone dehiscence,
and lesions associated with implants [82,83].
Novaes Jr et al. [84] treated class II furcation lesions in humans using a non-resorbable
BC membrane (Gengiflex®) with the GTR technique. Clinical evaluation of attachment
levels, radiographs, and a re-entry process were applied, and it was possible to observe the
closure of the defect. In [85], the same group successfully treated class II furcation lesions
in dogs with naturally occurring periodontitis using the same membrane.
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Adequate GTR results in periodontal defects in humans as well as in GTR for bone
formation were reported by Novaes [86,87] using the commercial membrane Gengiflex®. The
mentioned membrane was successfully applied in association with bone-integrated implants.
An et al. [88] prepared bacterial cellulose membranes (BCMs) and performed tests
in rats to assess guided bone regeneration. The electron beam (EI) irradiation technique
was used to increase the biodegradation of BC. Thus, EI-BCMs membranes were evaluated
by Fourier transform infrared attenuated spectroscopy (ATR-FTIR), scanning electron
microscopy (SEM), thermal gravimetric analysis (TGA), and other measures of wet tensile
strength as well as in vitro analysis to confirm cytocompatibility. All these chemical,
mechanical, and biological analyses showed effective EI–BCMs interactions with cells,
which promoted bone regeneration as a result.
On the other hand, surgical wounds of the oral mucosa are important issues in
dentistry, as shown in Figure 4. Small extent defects usually heal on primary closure, but
split or full-thickness grafts can be used for moderate ones. For defects involving most of
the buccal mucosa, there is a need for a second surgical area [83].
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Regarding issue reconstruction, there are several key re arkabl points. One f the
most relevant considerations is minimizing flap donor site morbidity, as it is known that
the gold standard of a graft material is the autogenous one. Some substitutes based on bio-
materials have been developed due to the following issues: morbidity of the donor site, the
risk of postoperative complications, the time of the procedure surgical, the unpredictable
resorption rate, and the limited amounts of soft tissue available [83].
Chiaoprakobkij et al. [89] prepared a novel three-dimensional composite based on
bacterial cellulose/alginate (BCA) to be used as a temporary dressing of oral surgical
flaps. In this study, HaCat cells (a keratinocyte cell line) were seeded on BC and BCA
scaffolds and compared to gingival fibroblast cells. It was observed that the last-mentioned
cell line had attached only onto the BCA sponge, which led researchers to conclude that
the BCA sponge scaffold has good potential for use in the oral cavity to cover surgical
wounds. Figure 4 illustrates some examples of the BC-based temporary wound dressing.
The material features a unique design: the outer layer is thicker to prevent bacterial
contamination and dehydration of the wound whereas the inner layer is porous and
designed to drain exudates.
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With respect to bone regeneration in dentistry as well in biomedicine, the autogenous
bone graft is still considered the gold standard. Although it is the only one that presents
osteoinductive, osteoconductive, and osteoprogenitor properties [90–92], it presents the
same risks and morbidity mentioned above. Furthermore, in terms of form and function,
each anatomical area offers unique challenges for bone reconstruction, and some graft
donor sites (like the fibula, scapula, radio, and iliac crest) can lead to increased morbid-
ity of the donor site [93]. As alternatives to regenerate bone tissue, allogeneic [94,95],
xenogenous [96], or synthetic biomaterials have been evaluated as grafts [97,98], as shown
in Figure 5.
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including the perspective of bone grafts substitutes.
At the current stage of development, the efforts of the most recent research seem
to be focused on the development of synthetic bone substitutes that are able to mimic
extracellular matrix functions of natural tissues and lead the host response, offering similar
results to the autograft implants [98,99].
BC has been recently exploited to design a tailorable matrix to synthesize different
types of calcium carbonate (CaCO3) and hydroxyapatite crystals from different starting
reagents with improved biocompatibility. For instance, in order to synthesize CaCO3 over
BC membranes, Stoica-Guzun et al. [100] used sodium carbonate (Na2CO3) and calcium
chloride (CaCl2) as starting reactants. Other authors [101,102] produced BC-hydroxyapatite
(Hap) nanocomposites by an optimal biomimetic mineralization route, inducing a negative
charge on BC nanofibrils, which stimulated the nucleation of Hap via simulated body fluid
(SBF) by the adsorption of polyvinylpyrrolidone (PVP). Before starting the biomimetic
mineralization process, Shi et al. [103] developed an alkaline treatment in order to improve
the mineralization efficiency and results. Further, Zhang et al. [104,105] promoted the
growth of Hap by using a phosphorylation reaction to introduce phosphate groups to
BC’s surface.
Dental implants are routine procedures in clinical practice, and often, the upper jaw
region has insufficient bone height for the procedure. Thus, Boyne and James [106] created
the maxillary sinus lifting technique by performing a graft, allowing implant insertion. In
this way, Koike et al. [107] performed frontal bone defects in 12 rabbits that were divided
in 4 groups: BC (BC grafting only), BMP-2 (treated only with BMP-2 solution), and BC
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+ BMP-2 (BC loaded with BMP-2 graft). As a result, BC maintained the graft space and
BMP-2 was released in a controlled manner into the target area, showing that BC + BMP-2
is a promising option to increase bone structure and for the placement of dental implants.
Saska et al. [108] evaluated the performance and biological properties of BC-Hap
nanocomposites in defects of the rat tibiae, aiming at bone repair. The BC-Hap membranes
were effective in inducing new bone formation as a slow reabsorption of the membranes
occurred, suggesting that longer periods are needed for this compound to be fully reab-
sorbed. Similarly, Tazi et al. [109] investigated BC-Hap nanocomposite for potential bone
regeneration. As a result, BC-Hap nanocomposites stimulated the growth of osteoblast
cells, with a high level of alkaline phosphatase activity, and which resulted in greater sites
of bone formation. The better the osteoblasts’ adhesion, the better BC-Hap biomaterials
are expected to offer cell proliferation and mineralization to encourage faster bone tissue
regeneration. Grande et al. [105] also developed BC-Hap scaffolds, presenting excellent
results concerning bone and connective tissue regeneration.
Coelho et al. [110] synthesized an innovative BC membrane associated with HA and
an antibody of a bone morphogenetic protein (anti-BMP-2) (BC-HA-anti-BMP-2). The SEM-
EDS and FTIR assays confirmed the presence of BC and HA. The proposed biomaterial
increased the expression of specific genes related to bone repair, proving to be non-cytotoxic,
genotoxic, nor mutagenic biomaterial by using MC3T3-E1 cells.
In an attempt to manufacture new biomaterials to induce bone repair, Fan and
coworkers [111] reported the introduction of goat bone apatite into BC. The designed
biomaterial demonstrated in vitro cell differentiation and also stimulated cell adhesion
and proliferation.
In reference to critical-sized calvarial defects in mice, Pigossi et al. [112] evaluated
the performance of BC-Hap composites associated with osteogenic growth peptide (OGP)
or pentapeptide OGP (10–14) as a potential biomaterial in bone regeneration. Thus, BC-
Hap-OGP, BC-Hap-OGP (10–14), and BC-Hap membranes were analyzed at 3, 7, 15, 30, 60,
and 90 days. Within each period of analysis, all specimens were evaluated by descriptive
histology, micro-computed tomography (µCT), VEGFR-2 (vascular endothelial growth
factor) quantification by ELISA, and gene expression of bone biomarkers by qPCR. The
researchers found that BC-Hap-OGP (10–14) and BC-Hap membranes reveled at 60 and
90 days a high percentage of bone formation by µCT. High expression of some bone
biomarkers, such as Tnfrsf11b and Alpl, Spp1, were also noticed, which lead them to
conclude that the BC-Hap membrane promoted better results related to bone formation in
critical-sized mice calvarial defects.
In terms of bone repair, Lee and coworkers [113] evaluated silk fibroin-BC membranes’
performance by successfully implanting them on bilateral segmental defects (2 mm in
length) of rats’ zygomatic arches. Complete healing of the surgical wounds was observed
at the 8-week follow-up against bone degeneration and necrosis when compared to the
control side without fixation.
Concerning the field of endodontics, Figure 6 summarize some BC applications. BC
has been reported as an innovative material for dental root canal treatment in animal
experiments by Yoshino et al. [114]. In comparison with commercial paper point mate-
rials (ISO 45 JM paper point, Morita, Osaka, Japan), BC did not exhibit harmful effects,
presenting safe compatibility and biological characteristics for dental root canal treatment.
Furthermore, BC-based biomaterials under wet conditions showed an excellent absorption
rate without deformation in relation to conventional ones.
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Figure 6. Some applications in endodontic and surgical areas. BC can be used as paper points to
dry the root canal, also allowing desired target drug delivery. Otherwise, BC nanowhiskers can be
obtained by different routes to reinforce dental cements and sutures in surgical procedures.
After the cleaning and drying steps related to endodontic treatment, the ideal sequence
concerns a complete sealing of the root canal space with filling materials.
Due to the excellent properties of BC, it can enable the production of whiskers in the
nanometric scale (nanowhiskers) that can be used as a reinforcement for other materials,
including dental cements. Thus, Jinga et al. [115] prepared BC nanowhiskers and used
commercial MTA (mineral trioxide aggregates) cement for the preparation of some com-
posites: MTA-E (mineral trioxide aggregates-experimental), composites MTA-10% biocell,
and MTA-33% biocell cements. Considering one day of hardening, XRD patterns, and the
thermal analysis data, they concluded that the presence of BC nanowhiskers accelerates the
hardening processes of MTA cement while a decrease in the amount of calcium hydroxide
crystals was noted. Thus, it was firstly reported in the literature that BC nanowhiskers
further the formation of crystalline hydrosilicates even after one day of hardening, without
affecting the viability and affinity of cells.
I tending to promote a tissue rege er tio response by applying the dental pulp
capping technique, Manzine Costa and cow rkers [116] developed an otolith/BC nanocom-
posite (OTL). Subsequently, exposed inciso dental pulps of ogs were divided int two
groups: BC/Otolith preparati n (OTL) an no protective material in the control group.
The teeth were en sealed with glass ionomer and h stological analyses were perf rmed
after 21 days. The proposed OTL nan c posite induced the formation of a tissue barrier
expressing ost oid-like characteristics of mineralization. The obtained re ults indicate
that otolith/cellulose b cterial nan composites might w rk as a potential en al pulp
capping bi material.
Recently, Voeicu et al. [117] synthesized a new family of composites starting from
min ral binder powders and biocellulose membranes, showing great applications in en-
dodontics. Silicate c me t synth sized through the ol-gel technique was prepared by the
addition of a BC polygranular pow er previously btained (crush d into micrometric par-
ticles via hydrothermal treatment). The resulting nanocomposite was investigated by SEM,
X-ray diffraction, thermal analysis, and other mechanical tests. The most important effect
Molecules 2021, 26, 49 11 of 16
of the BC content was observed in terms of shortening the setting time, where reduced
clinical care time is required. In vitro tests were performed, and all materials did not exert
cytotoxic effects, and promoted cell adhesion and proliferation. Moreover, they presented
a pronounced mineralization process in the simulated conditions. The authors concluded
that the proposed composite has high potential for applications in endodontic treatments,
mainly in root canal filling, root perforations, or dentin remineralization.
Regarding the reinforcement properties, the BC presented good results, improving the
mechanical properties when added to chitin fibers in surgical suture applications, and thus
setting up a promising new candidate as a BC-based medical suture for dentistry [118].
Carvalho et al. [119], in 2020, developed BNC-based patches containing both HA
and (Diclofenac) DCF. The objective of the material was the stimulation of healing of
the aphthous ulcers in recurrent aphthous stomatitis (RAS) and the mitigation of pain.
RAS is the most common form of oral mucosa ulcer, affecting from 5% to 66% of the
world’s population, which is also known as aphthae or canker sores. Despite manifesting
spontaneous healing in a few days, they can be extremely uncomfortable, causing stinging
pain and local inflammation. From this perspective, the freestanding membrane patches
were fabricated via simple diffusion of HA and DCF aqueous solutions into a wet BNC
three-dimensional porous network. The resultant nanostructured patches were thermal
resistant and stable up to 200 ◦C. In vitro assays showed that the patches were almost 100%
after 24 h of incubation. In addition, the swelling ability and DCF release was conducted in
simulated saliva, pointing to controlled drug-release purposes. The attained results hint at
the possibility of using the proposed BNC-HA-DCF-based patches to diminish and treat
aphthous stomatitis discomfort in the oral mucosa.
Finally, Table 1 shows a brief summary of the main BC advantages concerning its
properties to be applied in dental and oral fields.
Table 1. Summary of the main BC advantages to be to be applied in dental and oral fields.
Dental and Oral
Treatments Potential Use BC Advantages
Periodontal
treatment
Barrier membrane in GTR
technique
Novaes Jr et al., [84,85]
Novaes [86,87]
An et al., [88]
Allowed cell attachment and proliferation
Aesthetics importance restoration of oral function
Reduction in surgical steps




Surgical Wounds, flaps and RAS
ulcers
Chiaoprakobkij et al., [89]







Jinga et al., [115]
Scaffold for regenerative
Endodontic treatment
Manzine Costa et al., [116]
Voeicu et al., [117]
Accelerates the hardening processes of cement
Reinforce dental cements
Mimics extracellular matrix. Induces mineralized
barrier and apical closure
Dental surgery Surgical sutureWu et al., [118] Improve reinforcement and mechanical properties
5. Conclusions
As briefly shown, bacterial cellulose presents excellent properties that makes it a
wonderful renewable polymer synthesized from the bacterium Komagataeibacter xylinus
or related bacteria, which has attracted considerable interest and applications in several
biomedical and tissue engineering fields. Although BC’s advantages and properties are not
new, this review showed that BC can be explored as an innovative biomaterial for dental
and oral applications.
Probably, it is possible to observe an increasing degree of complexity in BC dental ap-
plications. Due to some BC properties, such as transparency, elasticity, durability, acting as
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a physical barrier against bacteria, hemostatic, easy handling, low cost, accelerated healing
process, and pain relief, firstly, pure BC membranes were directly applied to regenerate
the oral mucosa and periodontal tissue. Other properties, such as easy moldability and
natural 3-D well-arranged nanofibers, have inspired new BC-based nanocomposites to
perform dental endodontic treatment, surgical, reinforcement biomaterial, scaffolds, and
nanocomposites aimed at bone mineralization, for example.
There is huge potential to be explored, mainly related to tissues that have limitations
or difficulties in the healing process, such as nerves, cartilage, and bone. Although some BC-
based materials are focused on bone tissue, bone regeneration is a complex physiological
process that needs time for its formation. Bacterial cellulose is a good candidate for bone
repair as it presents versatility for the preparation of nanocomposites by a biomimetic
approach. Aligned to the current trends and taking advantage of biotechnology and the
high-value-added functional materials, many other novel features can be expected in
the near future, especially those related to 3-D nanomaterials and scaffold design. Thus,
the material properties can be enhanced when associated with a biomaterial because in
addition to promoting adhesion and proliferation of target cell lines, they can still act as
potential candidates in other applications associated with bone regeneration, like alveolar
bone regeneration and fixation, cleft palate, and dental implants.
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